Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 02, 2025

Get In Touch

Lupin Secures CDSCO Panel Nod for Phase IV Trial of Budesonide-Based COPD Inhaler Pharma News

Lupin Secures CDSCO Panel Nod for Phase IV Trial of Budesonide-Based COPD Inhaler

  • 19 September 2025
  • 1 month ago

CDSCO Cancels Registration Certificate of G3 Medical Systems for Import of Allergan Cosmetics Pharma News

CDSCO Cancels Registration Certificate of G3 Medical Systems for Import of Allergan Cosmetics

  • 19 September 2025
  • 1 month ago

Intas Pharma Secures CDSCO Panel Approval for Post-Marketing Study of Tacrolimus Enema Pharma News

Intas Pharma Secures CDSCO Panel Approval for Post-Marketing Study of Tacrolimus Enema

  • 17 September 2025
  • 1 month ago

Cocrystals of Approved APIs to Be Treated as New Drugs, Clarifies CDSCO Pharma News

Cocrystals of Approved APIs to Be Treated as New Drugs, Clarifies CDSCO

  • 17 September 2025
  • 1 month ago

CDSCO Panel Asks Wockhardt to Revise Phase III Study Protocol for Nafithromycin, Seeks Dosing, Control Arm Changes Pharma News

CDSCO Panel Asks Wockhardt to Revise Phase III Study Protocol for Nafithromycin, Seeks Dosing, Control Arm Changes

  • 16 September 2025
  • 1 month ago

Eris Lifesciences Secures CDSCO Panel Nod to Conduct BE Study on Dapagliflozin, Pioglitazone, Metformin FDC Pharma News

Eris Lifesciences Secures CDSCO Panel Nod to Conduct BE Study on Dapagliflozin, Pioglitazone, Metformin FDC

  • 15 September 2025
  • 1 month ago

AstraZeneca's Proposal to Increase Sample Size in Zibotentan-Dapagliflozin Global Trial Gets SEC Nod Pharma News

AstraZeneca's Proposal to Increase Sample Size in Zibotentan-Dapagliflozin Global Trial Gets SEC Nod

  • 14 September 2025
  • 1 month ago

CDSCO Panel Nod To Phase I Clinical Trial of Anticancer Drug Bevacizumab by Jeevan Scientific Pharma News

CDSCO Panel Nod To Phase I Clinical Trial of Anticancer Drug Bevacizumab by Jeevan Scientific

  • 14 September 2025
  • 1 month ago

Govt Allows Stickering, Orders New MRPs Post GST Reduction, AiMeD Welcomes Directive Pharma News

Govt Allows Stickering, Orders New MRPs Post GST Reduction, AiMeD Welcomes Directive

  • 14 September 2025
  • 1 month ago

Insufficient Efficacy, Safety Data: CDSCO Panel Rejects Zydus' Phase III CT Waiver Request for Voclosporin Pharma News

Insufficient Efficacy, Safety Data: CDSCO Panel Rejects Zydus' Phase III CT Waiver Request for Voclosporin

  • 13 September 2025
  • 1 month ago

Recent News

Himachal notifies Resident doctor policy 2025

  • 02 November, 2025

Pfizer files lawsuit against Metsera, its Director...

  • 02 November, 2025

Health Ministry achieves 3 Guinness World Records...

  • 02 November, 2025

Roche gets CE mark for Elecsys Dengue Ag test to d...

  • 02 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.